JP2025500824A5 - - Google Patents
Info
- Publication number
- JP2025500824A5 JP2025500824A5 JP2024534724A JP2024534724A JP2025500824A5 JP 2025500824 A5 JP2025500824 A5 JP 2025500824A5 JP 2024534724 A JP2024534724 A JP 2024534724A JP 2024534724 A JP2024534724 A JP 2024534724A JP 2025500824 A5 JP2025500824 A5 JP 2025500824A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- optionally substituted
- saturated
- branched
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291593P | 2021-12-20 | 2021-12-20 | |
| US63/291,593 | 2021-12-20 | ||
| US202263354640P | 2022-06-22 | 2022-06-22 | |
| US63/354,640 | 2022-06-22 | ||
| PCT/US2022/053193 WO2023121971A1 (en) | 2021-12-20 | 2022-12-16 | Nanomaterials comprising tetravalent lipid compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500824A JP2025500824A (ja) | 2025-01-15 |
| JP2025500824A5 true JP2025500824A5 (https=) | 2025-12-19 |
Family
ID=85157420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534724A Pending JP2025500824A (ja) | 2021-12-20 | 2022-12-16 | 四価脂質化合物を含むナノ材料 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240358841A1 (https=) |
| EP (1) | EP4452926A1 (https=) |
| JP (1) | JP2025500824A (https=) |
| AU (1) | AU2022421708A1 (https=) |
| CA (1) | CA3241503A1 (https=) |
| WO (1) | WO2023121971A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| AU2024279964A1 (en) * | 2023-05-30 | 2025-11-13 | Liberate Bio, Inc. | Lipid compounds, compositions, and uses thereof |
| WO2025059599A1 (en) * | 2023-09-13 | 2025-03-20 | Tessera Therapeutics, Inc. | Lipid nanoparticles for delivery of therapeutic payloads to cells |
| WO2025193861A2 (en) * | 2024-03-12 | 2025-09-18 | Tessera Therapeutics, Inc. | Lipid nanoparticles for delivery of therapeutic payloads to cells |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030083272A1 (en) | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| US6670499B1 (en) * | 1999-11-08 | 2003-12-30 | Daicel Chemical Industries, Ltd. | Adamantane derivatives and processes for the preparation thereof |
| US20040077888A1 (en) * | 2002-05-31 | 2004-04-22 | The Regents Of The University Of California | Polyamine-mediated transfection |
| JP2005181734A (ja) * | 2003-12-19 | 2005-07-07 | Fuji Photo Film Co Ltd | 画像記録材料 |
| CA2721333C (en) | 2008-04-15 | 2020-12-01 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP3083556B1 (en) * | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| JP6948313B6 (ja) | 2015-09-17 | 2022-01-14 | モデルナティエックス インコーポレイテッド | 治療剤の細胞内送達のための化合物および組成物 |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| EP3842538A4 (en) * | 2018-08-10 | 2022-06-08 | Kyoto University | METHOD OF TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID |
| US11845874B2 (en) * | 2019-01-24 | 2023-12-19 | Agfa Nv | Radiation curable inkjet inks for interior decoration |
| JP7693552B2 (ja) | 2019-02-13 | 2025-06-17 | ビーム セラピューティクス インク． | アデノシンデアミナーゼ塩基エディターおよびそれを用いて標的配列中の核酸塩基を改変する方法 |
-
2022
- 2022-12-16 JP JP2024534724A patent/JP2025500824A/ja active Pending
- 2022-12-16 WO PCT/US2022/053193 patent/WO2023121971A1/en not_active Ceased
- 2022-12-16 AU AU2022421708A patent/AU2022421708A1/en active Pending
- 2022-12-16 EP EP22851194.5A patent/EP4452926A1/en active Pending
- 2022-12-16 CA CA3241503A patent/CA3241503A1/en active Pending
-
2024
- 2024-06-18 US US18/746,791 patent/US20240358841A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025500824A5 (https=) | ||
| JP2025501731A5 (https=) | ||
| JP2024505449A5 (https=) | ||
| JP2024502948A5 (https=) | ||
| JP2024503441A5 (https=) | ||
| JP2024508347A5 (https=) | ||
| JP2024502954A5 (https=) | ||
| US11980595B2 (en) | Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases | |
| EA033966B1 (ru) | Стереохимически обогащенные композиции для доставки нуклеиновых кислот | |
| CA3206486A1 (en) | Antiviral agent | |
| JP2009533457A (ja) | Ｃ−ニトロソから誘導されるニトロキシル供与体 | |
| TWI910300B (zh) | 預防或治療ｅｇｆｒ功能異常相關的副作用的方法 | |
| JP2024503976A5 (https=) | ||
| CN117897162A (zh) | 治疗性核酸及其使用方法 | |
| JP2001520656A (ja) | 抗腫瘍剤としてのホルボールエステル類 | |
| EP4387952A1 (en) | Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereof | |
| JP3739098B2 (ja) | 長鎖アルコール類、アルカン類、脂肪酸類およびアミド類によるウイルスの阻害 | |
| CN120360978A (zh) | 化合物用于治疗射血分数保留的心衰的用途 | |
| WO2021129890A1 (zh) | 阻断微生物感染、降低胆固醇、防治相关肿瘤的药物及其应用 | |
| CN111803482B (zh) | 鹿茸单体在制备抑制乳腺肿瘤骨转移的药物中的应用及药物 | |
| FR3110836A1 (fr) | Utilisation de NMN pour réduire l’immunodépression et l’immunosénescence | |
| JP2021155397A (ja) | ベータコロナウイルス感染を防止する組成物 | |
| JP7290223B2 (ja) | ＩＬ－１β阻害薬 | |
| WO2024078614A1 (zh) | 用于递送生物活性成分的氨基脂质化合物和脂质纳米颗粒 | |
| KR20240167649A (ko) | 아미노 지질 화합물, 이의 제조 방법, 이의 조성물 및 이의 용도 |